Multinational Point Prevalence Study on the Management of Diabesity in Hospitals (DiabesityDay)

Multinational Cross-sectional Review of Diabetes and Obesity Management in Hospitals Across Europe: The DIABESITY Survey

Diabetes related to obesity ("diabesity") is becoming increasingly prevalent. Hospitalizations among people with diabetes are frequent and glycaemic control is often suboptimal during these stays.

However, the pharmacological treatment of diabesity has made significant progress in recent years.

The objective of this study is to assess the management of diabesity in the international hospital setting. Aims include:

1. to determine the prevalence of causes and duration of hospitalization
2. to investigate the treatments used
3. to determine individual metabolic control achived This is a cross-sectional multi-centre study in which researchers will conduct a one-day point prevalence assessment in internal medicine wards.

Study Overview

• Status: Active, not recruiting
• Conditions: Obesity; Diabetes Mellitus
• Intervention / Treatment: Other: Routine care for people with diabetes, with or without obesity, in the hospital setting

• Study Type: Observational
• Enrollment (Estimated): 400

Contacts and Locations

Study Locations

• Austria
  • Vienna, Austria, 1090
    • Medical University of Vienna
• Czechia
  • Prague, Czechia
    • General University Hospital in Prague
• Germany
  • Aachen, Germany
    • University Hospital RWTH Aachen
• Greece
  • Thessaloniki, Greece
    • Hippokration General Hospital, Aristotle University of Thessaloniki
• Israel
  • Petah Tikva, Israel
    • Rabin Medical Center, Hasharon Hospital
• Latvia
  • Riga, Latvia
    • Riga East Clinical University Hospital
• Russian Federation
  • Rostov-on-Don, Russian Federation
    • Rostov State Medical University
• Turkey
  • Istanbul, Turkey
    • Kanuni Sultan Suleyman Training and Research Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: No

• Sampling Method: Non-Probability Sample

Study Population

Adults (age ≥ 18 years) with diabetes who are admitted to an internal medicine ward of a participating medical centre at the time of the study

Description

Inclusion Criteria:

• Hospitalized at the time of the survey for any cause
• Diabetes diagnosis (Known / documented in medical history or newly diagnosed using ADA diagnostic criteria)
• Age ≥ 18 years
• Written informed consent

Exclusion Criteria:

• Patients in wards and units other than internal medicine wards (such as outpatient areas, emergency departments, skilled nursing and intensive care units, etc.)
• Paediatric patients (Age < 18 years)
• Patients without a diabetes diagnosis

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Number of point-of-care glucose values	Mean number of point-of-care glucose measurements during hospitalization	3 days

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Severe hypoglycaemia	Severe hypoglycaemia during admission (glucose <40mg/dL)	From day of admission to the day of data collection, i.e., November 14, 2024

Other Outcome Measures

Outcome Measure	Measure Description	Time Frame
Diabetes treatment during hospitalization	Diabetes treatment used during the time of hospitalization	From day of admission to the day of data collection, i.e., November 14, 2024
Insulin regimen during hospitalization	Insulin regimen used during the time of hospitalization (e.g., correction, basal, prandial bolus)	From day of admission to the day of data collection, i.e., November 14, 2024

Collaborators and Investigators

• Sponsor: Medical University of Vienna
• Collaborators: Charles University, Czech Republic; Rabin Medical Center; Kanuni Sultan Suleyman Training and Research Hospital; Aristotle University Of Thessaloniki; Medical University Innsbruck; Hospital Regional de Malaga; Riga East Clinical University Hospital; University Hospital Bratislava; University Hospital, Aachen; San Raffaele University Hospital, Italy; Rostov State Medical University; Hospital de Cascais Dr. José de Almeida (Portugal); Centre Hospitalier Universitaire Sétif, Service Médecine Interne (Algeria); Complejo Hospitalario de Especialidades Juan Ramón Jimenez; Hospital Marina Baixa
• Investigators: Study Director: Alexandra Kautzky-Willer, Prof, Medical University of Vienna

Study record dates

Study Major Dates

• Study Start (Actual): November 13, 2024
• Primary Completion (Actual): March 18, 2025
• Study Completion (Estimated): May 31, 2025

Study Registration Dates

• First Submitted: November 6, 2024
• First Submitted That Met QC Criteria: November 7, 2024
• First Posted (Actual): November 8, 2024

Study Record Updates

• Last Update Posted (Actual): May 8, 2025
• Last Update Submitted That Met QC Criteria: May 5, 2025
• Last Verified: May 1, 2025

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Nutrition Disorders; Overnutrition; Body Weight; Overweight; Obesity
• Other Study ID Numbers: EK 1828/2024

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO
• IPD Plan Description: Patient data will only be shared in aggregated form.

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No